SCHEMBL23770844

SCHEMBL23770844

Cc1cccc(C)c1-c1nc(NSc2cccc(N3CCC(C)(C(=O)O)CC3)n2)ccc1Cl

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 12/20 0.33
HDAC3 O15379 2/20 0.32
HDAC4 P56524 2/20 0.32
HDAC1 Q13547 2/20 0.32
HDAC7 Q8WUI4 2/20 0.32
HDAC2 Q92769 2/20 0.32
HDAC10 Q969S8 2/20 0.32
HDAC11 Q96DB2 2/20 0.32
HDAC8 Q9BY41 2/20 0.32
HDAC6 Q9UBN7 2/20 0.32
HDAC9 Q9UKV0 2/20 0.32
HDAC5 Q9UQL6 2/20 0.32
DGAT1 O75907 1/20 0.32
KCNH2 Q12809 1/20 0.32
SMO Q99835 1/20 0.32
RORC P51449 1/20 0.31
CNR1 P21554 2/20 0.31
CNR2 P34972 1/20 0.31
S1PR1 P21453 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770659 0.91 PTPN11 (0.36) PTPN11HDAC3HDAC4HDAC1HDAC7
SCHEMBL23770800 0.91 RORC (0.32) PTPN11HDAC3HDAC4HDAC1HDAC7
SCHEMBL19970116 0.90 DGAT1 (0.35) PTPN11DGAT1KCNH2CNR1CNR2
SCHEMBL23770829 0.89 HDAC3 (0.33) PTPN11HDAC3HDAC4HDAC1HDAC7
SCHEMBL23770871 0.88 MEN1 (0.38) PTPN11HDAC3HDAC4HDAC1HDAC7
SCHEMBL23770892 0.87 RORC (0.35) PTPN11RORC
SCHEMBL23770874 0.86 SMO (0.31) PTPN11HDAC3HDAC4HDAC1HDAC7
SCHEMBL23770884 0.85 RORC (0.36) PTPN11HDAC3HDAC4HDAC1HDAC7
SCHEMBL23770837 0.85 SMO (0.34) SMOCNR1CNR2
SCHEMBL23770499 0.84 PTPN11 (0.36) PTPN11HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed